Selection of new ERA Chair holder for MAGBIOVIN project

We are happy to announce that the Selection Panel has chosen Dr. Zeljko Prijovic as the best candidate for the ERA Chair holder position. As an outstanding and internationally recognized scientist in the field of biochemistry and enzymology, he was selected to be the new Scientific Coordinator of the MagBioVin (više…)

Open ERA Chair Holder position

The Vinca Institute, University of Belgrade, Serbia, announces the open ERA Chair Holder position for the MagBioVin project, funded by the grant of 2.4 million EUR within the FP7-ERAChairs-Pilot Call-2013 programme  since May 5th 2014. The position is a replacement for the recent ERA Chair stepping down and will be effective Sep 1st 2016. Through the MagBioVin project, EC has been supporting the Vinca Institute to upgrade its capacities for the highly specialized research on activated magnetic nanoparticles (MNP) and radionuclide labeled magnetic nanoparticles for application in biosciences, pharmacy and medicine. During past two years, MagBioVin project has been significantly advancing and gained expertise in developing magnetic and radioactive nanomaterial for diagnostics and therapy of cancer and related diseases. The key role of the new ERA Chair holder will be in assuring continuity of the recent and envisioning new research directions. Toward that goal, the ERA Chair should possess a research vision complementary with past/recent status of MagBioVin project.  Additionally, s/he will assure improvement of existing organizational structure, national and international networking, and communication with stakeholders. The final Project goal is to raise both human and experimental capacities of the Vinca Institute to the level that ensures considerable scientific and technological impact within ERA, and its ability to compete with leading EU research institutions. The Chair holder has to be an internationally renewed researcher (category R3 or preferably R4 in the European Framework for research careers), experienced in multidisciplinary research covering biochemistry/biophysics/pharmacology field, with a clear vision of research complementary with recent MagBioVin interests, ideally with expertise in nanomedicine and translational anticancer research.